Results 171 to 180 of about 1,977 (181)

Risdiplam auch als Tablette verfügbar

DNP – Die Neurologie & Psychiatrie
openaire   +1 more source

In brief: Risdiplam (Evrysdi) for spinal muscular atrophy.

The Medical letter on drugs and therapeutics, 2021
openaire   +1 more source

Efficacy and safety of risdiplam in adults with 5q-associated spinal muscular atrophy: a nationwide observational cohort study in Austria

EClinicalMedicine
Jakob Rath, Håkan Cetin, Corinne Gosewina Cornelia Horlings   +2 more
exaly  

Evaluation of risdiplam efficacy in 5q spinal muscular atrophy: A systematic comparison of electrophysiologic with clinical outcome measures

European Journal of Neurology
Tobias Kessler, Wolfgang Wick, Markus Weiler   +2 more
exaly  

Global Risdiplam Compassionate Use Program for Patients with Type 1 or 2 Spinal Muscular Atrophy

Clinical Therapeutics
Ksenija Gorni
exaly  

Comparative efficacy of risdiplam and nusinersen in Type 2 and 3 spinal muscular atrophy patients: A cohort study using real-world data

Journal of Neuromuscular Diseases
Ali Abbaskhanian
exaly  

Clinical Application of Risdiplam in 5q Spinal Muscular Atrophy: A Narrative Review

British Journal of Hospital Medicine (London, England: 2005)
Han-Yu Dong
exaly  

An updated systematic review on spinal muscular atrophy patients treated with nusinersen, onasemnogene abeparvovec (at least 24 months), risdiplam (at least 12 months) or combination therapies

European Journal of Paediatric Neurology
Doris Giess
exaly  

Risdiplam - Ein Hoffnungsträger bei spinaler Muskelatrophie

Österreichische Apothekerzeitung, 2019
openaire   +1 more source

SMA Hastalarında Nusinersen ve Risdiplam Tedavi Tercihleri ile Risdiplam Geçişi Sonrası İlk Gözlemler: Anket Çalışması

BAYSAL, AHMET, ÇARMAN, KÜRŞAT BORA, YARAR, COŞKUN, UĞUR AYDIN, ÖZLEM, YÜCEL ŞEN, ARİFE DERDA   +4 more
openaire   +1 more source